Vivos Therapeutics(VVOS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VVOS Vivos Therapeutics

Trading 09-25 11:42:22 EDT

0.1427

-0.0028

-1.92%

High0.1465	Low0.1421	Vol215.16K
Open0.1459	D1 Closing0.1455	Amplitude3.02%
Mkt Cap2.87M	Tradable Cap2.85M	Total Shares20.12M
T/O31.01K	T/O Rate1.08%	Tradable Shares19.98M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VVOS","market":"US","secType":"STK","nameCN":"Vivos Therapeutics","latestPrice":0.1427,"timestamp":1790350877671,"preClose":0.1455,"halted":0,"volume":215155,"delay":0,"changeRate":-0.019243986254295513,"floatShares":19975630,"shares":20118000,"eps":-1.826661,"marketStatus":"Trading","change":-0.0028,"latestTime":"09-25 11:42:22 EDT","open":0.1459,"high":0.1465,"low":0.1421,"amount":31007.041309499997,"amplitude":0.030241,"askPrice":0.1434,"askSize":766,"bidPrice":0.1412,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.826661,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790366400000},"marketStatusCode":2,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":0.1455,"preHourTrading":{"tag":"盘前","latestPrice":0.1465,"preClose":0.1455,"latestTime":"09:18 EDT","volume":36204,"amount":5277.53564268,"timestamp":1790342299271,"change":0.001,"changeRate":0.006873,"amplitude":0.058419},"postHourTrading":{"tag":"盘后","latestPrice":0.1495,"preClose":0.1455,"latestTime":"19:47 EDT","volume":25048,"amount":3661.0835,"timestamp":1790293664557,"change":0.004,"changeRate":0.027491,"amplitude":0.035739},"volumeRatio":0.533117,"impliedVol":2.594,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VVOS","defaultTab":"news","newsList":[{"id":"2666370491","title":"Vivos Therapeutics Amends 8-K to Correct Report Date to Sept. 2, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370491?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:30","pubTimestamp":1788903002,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics amends 8-K to correct report date to Sept. 2, 2026Vivos Therapeutics filed an 8-K/A to correct the “Date of Report” in its Sept. 4 Form 8-K.The filing changes the date to Sept. 2, 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLYtgP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665437876","title":"Vivos Therapeutics Announces Material Debt Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2665437876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665437876?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:45","pubTimestamp":1788871500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA2CFXKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314321","title":"Vivos Therapeutics Exchanges USD 2.86 Million Streeterville Note Principal for up to 11,445,080 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665314321?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:02","pubTimestamp":1788861767,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics exchanges USD 2.86 million Streeterville note principal for up to 11,445,080 sharesVivos Therapeutics agreed to exchange $2.86 million of secured promissory note principal for up to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbXlsD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662249093","title":"Vivos Therapeutics, SPCVA to launch regional sleep testing and treatment center","url":"https://stock-news.laohu8.com/highlight/detail?id=2662249093","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662249093?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:50","pubTimestamp":1787921410,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics (VVOS) announced the execution of definitive collaboration and operating agreements with South Palm Cardiovascular Associates, o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-spcva-to-launch-regional-sleep-testing-and-treatment-center-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-spcva-to-launch-regional-sleep-testing-and-treatment-center-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093558","title":"Vivos Therapeutics Partners with South Palm Cardiovascular to Launch Florida Sleep Testing, Treatment Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093558","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093558?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:45","pubTimestamp":1787921127,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics partners with South Palm Cardiovascular to launch Florida sleep testing, treatment centerVivos Therapeutics signed definitive collaboration and operating agreements with South Palm ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL1rTXkP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","BCDF","SG9999014039.USD","BK4588","SG9999014005.SGD","BK4112","NDAQ","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509330","title":"Vivos Therapeutics - Expects to Hold 75% Majority Interest in Aim Florida","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662509330?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:45","pubTimestamp":1787921100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUAFNYTX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093372","title":"Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093372?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:45","pubTimestamp":1787921100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUAFNYTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093306","title":"Vivos Therapeutics - Center Expected to Begin Treating Patients and Generating Revenue in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093306?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:45","pubTimestamp":1787921100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUAFNYTX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662309737","title":"Vivos Therapeutics reports new patient referrals at Nevada Sleep & Airway","url":"https://stock-news.laohu8.com/highlight/detail?id=2662309737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662309737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:56","pubTimestamp":1787662583,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics (VVOS) announced that new OSA patient referrals flowing into its Nevada Sleep & Airway Medicine Centers have increased 212% over...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-reports-new-patient-referrals-at-nevada-sleep-airway-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-reports-new-patient-referrals-at-nevada-sleep-airway-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660387172","title":"Vivos Therapeutics opens sleep testing, treatment facility in Nevada","url":"https://stock-news.laohu8.com/highlight/detail?id=2660387172","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660387172?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:30","pubTimestamp":1787236219,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics (VVOS) announced the official Grand Opening of its latest state-of-the-art diagnostic, testing, and treatment location in Hender...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-opens-sleep-testing-treatment-facility-in-nevada-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vivos-therapeutics-opens-sleep-testing-treatment-facility-in-nevada-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660389238","title":"Vivos Therapeutics Opens Henderson, Nevada Sleep Testing and Treatment Center, Targets over $10 Million Annual Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2660389238","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660389238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:24","pubTimestamp":1787235868,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics opens Henderson, Nevada sleep testing and treatment center, targets over $10 million annual capacityVivos Therapeutics opened a new sleep testing and treatment facility in Henderson","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL4m9td:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BQXX3F31.USD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4196","IE00BN0W2W23.USD","VVOS","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4588","SG9999014005.SGD","BCDF","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660148354","title":"Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Revenue Up 35%, Liquidity Risks Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=2660148354","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660148354?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:00","pubTimestamp":1786953657,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics (VVOS) Q2 2026 earnings call: revenue rose 35% to $5.2M as management outlined growth plans amid liquidity and Nasdaq risks.","market":"sh","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock4.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/transcripts/262111285-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112149","title":"Vivos Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112149","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112149?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:02","pubTimestamp":1786741337,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryVivos Therapeutics IncVVOS.OQreported a quarterly adjusted loss of 31 cents per share for the quarter ended June ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121863","title":"Vivos Therapeutics Q2 Revenue Rises 35% on Service Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121863","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121863?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:40","pubTimestamp":1786740020,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics Q2 revenue rises 35% on service growthOverviewU.S. sleep apnea device maker's Q2 revenue rose 35% yr/yr, driven by service growthGross margin improved to 57% from 55% a year ago on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVAH","BK4139","VVOS","SERA","BK4196","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659290111","title":"Vivos Therapeutics Q2 Net Income USD -5.523 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659290111","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659290111?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:38","pubTimestamp":1786739933,"startTime":"0","endTime":"0","summary":"Aug 14 (Reuters) - Vivos Therapeutics Q2 operating income USD -4.825 million.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 14-AUG-202620:21:49.94 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nRSD5fRyxs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129439","title":"Vivos Therapeutics Q2 Gross Profit USD 2.953 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129439?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:28","pubTimestamp":1786739338,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLXDH6D79:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129577","title":"Vivos Therapeutics Q2 EPS $(0.31) Beats $(0.36) Estimate, Sales $5.153M Miss $5.367M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129577","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129577?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:16","pubTimestamp":1786738606,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.36) by 13.89 percent. This is a 43.64 percent increase over losses of $(0.55) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61227679/vivos-therapeutics-q2-eps-0-31-beats-0-36-estimate-sales-5-153m-miss-5-367m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vivos Therapeutics Q2 EPS $(0.31) Beats $(0.36) Estimate, Sales $5.153M Miss $5.367M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659142028","title":"Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2659142028","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659142028?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:45","pubTimestamp":1786711500,"startTime":"0","endTime":"0","summary":"Call scheduled for today, Friday, August 14, 2026, at 5:00 pm ETLITTLETON, Colo., Aug.  14, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345341/0/en/vivos-therapeutics-schedules-release-of-second-quarter-2026-financial-results-and-conference-call.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4211","VVOS","CARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659437521","title":"Vivos Therapeutics Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2659437521","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659437521?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:03","pubTimestamp":1786705385,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics Inc <VVOS.OQ> expected to post a loss of39cents a share - Earnings PreviewVivos Therapeutics IncVVOS.OQVVOS.Ois expected to  show a rise in quarterly revenue when it reports  result","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B0LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","VVOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946728","title":"Vivos Therapeutics Strengthens IP for Sleep Apnea Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946728","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946728?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:31","pubTimestamp":1786483914,"startTime":"0","endTime":"0","summary":"Vivos Therapeutics ( ($VVOS) ) has issued an announcement. On August 5, 2026, Vivos Therapeutics announced the issuance of U.S. Patent No. 12,697,1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-strengthens-ip-for-sleep-apnea-devices?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivos-therapeutics-strengthens-ip-for-sleep-apnea-devices?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2463526074.USD","VVOS","IE00B3T34201.USD","LU1481600234.SGD","BK4196","BK4588","BK4136","LU1169590202.USD","LU1169589451.USD","CUT","WOOD","BK4585","LU1487256676.USD","IP","LU1481599808.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivos.com","stockEarnings":[{"period":"1week","weight":-0.1733},{"period":"1month","weight":-0.4514},{"period":"3month","weight":-0.6749},{"period":"6month","weight":-0.8735},{"period":"1year","weight":-0.9582},{"period":"ytd","weight":-0.9283}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.205284},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.068873},{"month":3,"riseRate":0,"avgChangeRate":-0.209794},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.183475},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.065034},{"month":6,"riseRate":0.5,"avgChangeRate":-0.015118},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.103228},{"month":8,"riseRate":0.5,"avgChangeRate":0.055178},{"month":9,"riseRate":0,"avgChangeRate":-0.25296},{"month":10,"riseRate":0.2,"avgChangeRate":-0.105489},{"month":11,"riseRate":0.4,"avgChangeRate":1.251693},{"month":12,"riseRate":0.2,"avgChangeRate":-0.12992}],"exchange":"NASDAQ","name":"Vivos Therapeutics","nameEN":"Vivos Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vivos Therapeutics(VVOS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vivos Therapeutics(VVOS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vivos Therapeutics,VVOS,Vivos Therapeutics股票,Vivos Therapeutics股票老虎,Vivos Therapeutics股票老虎国际,Vivos Therapeutics行情,Vivos Therapeutics股票行情,Vivos Therapeutics股价,Vivos Therapeutics股市,Vivos Therapeutics股票价格,Vivos Therapeutics股票交易,Vivos Therapeutics股票购买,Vivos Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vivos Therapeutics(VVOS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vivos Therapeutics(VVOS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction